The responsibilities of estrogens and androgens have been clearly proven about breast and prostate cancers, while estrogen receptor-alpha (ERα) and retinoic acid receptor-alpha (RARα) have been extensively studied for their involvement in cancer risk, also with regard to oral cancers. Here, RARA is linked to prostate cancer.